HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Macphee, C. H. Articles by Beavo, J. A. Search for Related Content PubMed PubMed Citation Articles by Macphee, C. H. Articles by Beavo, J. A. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 263, Issue 21, 10353-10358, Jul, 1988

Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets

CH Macphee, DH Reifsnyder, TA Moore, KM Lerea and JA Beavo
Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195.

Agents such as prostaglandins E1 and I2 which elevate cAMP levels in platelets also increase cAMP phosphodiesterase activity. Since much of the cAMP phosphodiesterase activity in human platelets is due to the cGMP-inhibited isozyme (Macphee, C. H., Harrison, S. A., and Beavo, J. A. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 6600-6663), we examined the regulation of this isozyme by prostaglandins E1 and I2 in intact platelets. Because this isozyme is a minor component of platelet protein, normally requiring several thousand-fold purification to achieve homogeneity, a specific monoclonal antibody (CGI-5) was utilized to identify and isolate the cGMP-inhibited phosphodiesterase activity. Treatment of intact platelets with the prostaglandins promoted an increase in the phosphorylation state of the cGMP-inhibited phosphodiesterase and a corresponding increase in phosphodiesterase activity. The effect on activity and phosphorylation of the cGMP- inhibited phosphodiesterase was observed within 2 min after intact platelets were exposed to the prostaglandins. The half-maximal effective dose for prostaglandin I2 (10 nM) was approximately 10-fold lower than that for prostaglandin E1. The phosphorylated, cGMP- inhibited isozyme migrated as a 110-kDa peptide following sodium dodecyl sulfate gel electrophoresis. Direct in vitro phosphorylation of the platelet cGMP-inhibited phosphodiesterase by the catalytic subunit of cAMP-dependent protein kinase caused a similar increase in phosphodiesterase activity. Treatment with PKI peptide, a specific inhibitor of cAMP-dependent protein kinase, blocked the phosphorylation and the effect on activity. Taken together, the data strongly suggest that the effects of prostaglandins E1 and I2 on platelet phosphodiesterase activity are mediated by a direct cAMP-dependent protein kinase-catalyzed phosphorylation of the cGMP-inhibited phosphodiesterase isozyme.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Vandeput, S. L. Wolda, J. Krall, R. Hambleton, L. Uher, K. N. McCaw, P. B. Radwanski, V. Florio, and M. A. Movsesian Cyclic Nucleotide Phosphodiesterase PDE1C1 in Human Cardiac Myocytes J. Biol. Chem., November 9, 2007; 282(45): 32749 - 32757. [Abstract] [Full Text] [PDF]

				R. Fischmeister, L. R.V. Castro, A. Abi-Gerges, F. Rochais, J. Jurevicius, J. Leroy, and G. Vandecasteele Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases Circ. Res., October 13, 2006; 99(8): 816 - 828. [Abstract] [Full Text] [PDF]

				M. Bajpai, S. E. Fiedler, Z. Huang, S. Vijayaraghavan, G. E. Olson, G. Livera, M. Conti, and D. W. Carr AKAP3 Selectively Binds PDE4A Isoforms in Bovine Spermatozoa Biol Reprod, January 1, 2006; 74(1): 109 - 118. [Abstract] [Full Text] [PDF]

				F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum, J.-L. Mazet, D. M. F. Cooper, and R. Fischmeister Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes: AN IN VIVO STUDY USING ADENOVIRUS-MEDIATED EXPRESSION OF CNG CHANNELS J. Biol. Chem., December 10, 2004; 279(50): 52095 - 52105. [Abstract] [Full Text] [PDF]

				M. A. Nolan, D. F. Babcock, G. Wennemuth, W. Brown, K. A. Burton, and G. S. McKnight Sperm-specific protein kinase A catalytic subunit C{alpha}2 orchestrates cAMP signaling for male fertility PNAS, September 14, 2004; 101(37): 13483 - 13488. [Abstract] [Full Text] [PDF]

				I. Faerge, B. Terry, J. Kalous, P. Wahl, M. Lessl, J.L. Ottesen, P. Hyttel, and C. Grondahl Resumption of Meiosis Induced by Meiosis-Activating Sterol Has a Different Signal Transduction Pathway than Spontaneous Resumption of Meiosis in Denuded Mouse Oocytes Cultured In Vitro Biol Reprod, December 1, 2001; 65(6): 1751 - 1758. [Abstract] [Full Text] [PDF]

				T. C. Rich, K. A. Fagan, T. E. Tse, J. Schaack, D. M. F. Cooper, and J. W. Karpen A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell PNAS, October 12, 2001; (2001) 221381398. [Abstract] [Full Text] [PDF]

				Y. Kenan, T. Murata, Y. Shakur, E. Degerman, and V. C. Manganiello Functions of the N-terminal Region of Cyclic Nucleotide Phosphodiesterase 3 (PDE 3) Isoforms J. Biol. Chem., April 14, 2000; 275(16): 12331 - 12338. [Abstract] [Full Text] [PDF]

				J. Lim, G. Pahlke, and M. Conti Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation. IDENTIFICATION AND FUNCTION OF AN INHIBITORY DOMAIN J. Biol. Chem., July 9, 1999; 274(28): 19677 - 19685. [Abstract] [Full Text] [PDF]

				S. Iona, M. Cuomo, T. Bushnik, F. Naro, C. Sette, M. Hess, E. R. Shelton, and M. Conti Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain Mol. Pharmacol., January 1, 1998; 53(1): 23 - 32. [Abstract] [Full Text]

				C. J. Smith, R. Huang, D. Sun, S. Ricketts, C. Hoegler, J.-Z. Ding, R. A. Moggio, and T. H. Hintze Development of Decompensated Dilated Cardiomyopathy Is Associated With Decreased Gene Expression and Activity of the Milrinone-Sensitive cAMP Phosphodiesterase PDE3A Circulation, November 4, 1997; 96(9): 3116 - 3123. [Abstract] [Full Text]

				A. Lochhead, E. Nekrasova, V. Y. Arshavsky, and N. J. Pyne The Regulation of the cGMP-binding cGMP Phosphodiesterase by Proteins That Are Immunologically Related to gamma  Subunit of the Photoreceptor cGMP Phosphodiesterase J. Biol. Chem., July 18, 1997; 272(29): 18397 - 18403. [Abstract] [Full Text] [PDF]

				C. Sette and M. Conti Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase. INVOLVEMENT OF SERINE 54IN THE ENZYME ACTIVATION J. Biol. Chem., July 12, 1996; 271(28): 16526 - 16534. [Abstract] [Full Text] [PDF]

				J. Kasuya, H. Goko, and Y. Fujita-Yamaguchi Multiple Transcripts for the Human Cardiac Form of the cGMP-inhibited cAMP Phosphodiesterase J. Biol. Chem., June 16, 1995; 270(24): 14305 - 14312. [Abstract] [Full Text] [PDF]

				K. Yuasa, J. Kotera, K. Fujishige, H. Michibata, T. Sasaki, and K. Omori Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression J. Biol. Chem., September 29, 2000; 275(40): 31469 - 31479. [Abstract] [Full Text] [PDF]

				T. C. Rich, K. A. Fagan, T. E. Tse, J. Schaack, D. M. F. Cooper, and J. W. Karpen A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell PNAS, November 6, 2001; 98(23): 13049 - 13054. [Abstract] [Full Text] [PDF]